Search

Displaying results 3551 - 3560 of 10000 in total
  1. Drug

    Vanadium

    go.drugbank.com/drugs/DB13971
    Approved

    Mixtures: Multi Cal Mag Liquid, Rocky Mountain Multiple Vit and Min Mega TabCategories: Diet, Food, and Nutrition
  2. Drug

    Magnesium gluconate

    go.drugbank.com/drugs/DB13749
    ApprovedWithdrawn

    Magnesium is ubiquitous in the human body, and is naturally present in many foods, added to other food products, available as a dietary supplement and used as an ingredient in some medicines (such as antacids … This drug has been studied in the prevention of pregnancy-induced hypertension, and has displayed promising results [A32807].

    Mixtures: NUTROPLEX LIQUID WITH IRON AND LYSINE, K-medCategories: Alimentary Tract and Metabolism
  3. Drug

    Poliovirus type 1 antigen (formaldehyde inactivated)

    go.drugbank.com/drugs/DB10795
    ApprovedInvestigational

    Poliovirus type 1 antigen is a suspension of poliovirus Type 1 (Mahoney) used in the active immunization of infants (as young as 6 weeks of age), children, and adults for the prevention of poliomyelitis … caused by poliovirus Type 1.

    Synonyms: Inactivated poliovirus type IMixtures: VeroPol Injektionslösung in einer Fertigspritze, -POLIO SUSPENSION FOR INJECTION IN PRE-FILLED SYRINGE
  4. Drug

    Naloxegol

    go.drugbank.com/drugs/DB09049
    ApprovedInvestigational

    It was approved by the FDA in September 2014 and is indicated for the treatment of opioid-induced constipation (OIC) in adult patients with chronic non‑cancer pain. … Naloxegol, for "PEGylated naloxol" is a peripherally-selective opioid antagonist developed by AstraZeneca.

    Categories: Alimentary Tract and Metabolism, Compounds used in a research, industrial, or household setting
  5. Target

    Cyanocobalamin reductase / alkylcobalamin dealkylase

    go.drugbank.com/bio_entities/BE0002175
    TargetHumans

    Cysteine and homocysteine cannot substitute for glutathione in this reaction (PubMed:19801555) … The processing of cobalamin in the cytosol occurs in a multiprotein complex composed of at least MMACHC, MMADHC, MTRR (methionine synthase reductase) and MTR (methionine synthase) which may contribute

    Synonyms: Methylmalonic aciduria and homocystinuria type C protein
  6. Target

    Vesicular inhibitory amino acid transporter

    go.drugbank.com/bio_entities/BE0002308
    TransporterHumans

    The transport is equally dependent on the chemical and electrical components of the proton gradient (By similarity). May also transport beta-alanine (By similarity).

    Synonyms: GABA and glycine transporter
  7. Target

    All-trans-retinol 13,14-reductase

    go.drugbank.com/bio_entities/BE0002320
    TargetHumans

    Does not exhibit any activity toward all-trans-retinoic acid, nor 9-cis, 11-cis or 13-cis-retinol isomers. May play a role in the metabolism of vitamin A. … May play a role in adipocyte differentiation

    Synonyms: PPAR-alpha-regulated and starvation-induced gene protein
  8. Target

    Complement C4-A

    go.drugbank.com/bio_entities/BE0004685
    TargetHumans

    Precursor of non-enzymatic components of the classical, lectin and GZMK complement pathways, which consist in a cascade of proteins that leads to phagocytosis and breakdown of pathogens and signaling that

    Synonyms: C3 and PZP-like alpha-2-macroglobulin domain-containing protein 2
  9. Target

    Complement C4-B

    go.drugbank.com/bio_entities/BE0004686
    TargetHumans

    Precursor of non-enzymatic components of the classical, lectin and GZMK complement pathways, which consist in a cascade of proteins that leads to phagocytosis and breakdown of pathogens and signaling that

    Synonyms: C3 and PZP-like alpha-2-macroglobulin domain-containing protein 3
  10. Drug

    Lifileucel

    go.drugbank.com/drugs/DB17107
    ApprovedInvestigational

    ] Lifileucel was granted accelerated approval by the FDA on February 16, 2024, for the treatment of unresectable or metastatic melanoma. … Lifileucel is a tumour-derived autologous T cell immunotherapy composed of a suspension of tumour-derived T cells from the patient [L50171] which undergo isolation, ex vivo expansion, and activation[A263341

    Categories: Antineoplastic cell and gene therapy, Antineoplastic and Immunomodulating Agents